| Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1 E McElvania TeKippe, IC Allen, PD Hulseberg, JT Sullivan, JR McCann, ... PloS one 5 (8), e12320, 2010 | 194 | 2010 |
| Protein export systems of Mycobacterium tuberculosis: novel targets for drug development? ME Feltcher, JT Sullivan, M Braunstein Future microbiology 5 (10), 1581-1597, 2010 | 135 | 2010 |
| The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages JT Sullivan, EF Young, JR McCann, M Braunstein Infection and immunity 80 (3), 996-1006, 2012 | 130 | 2012 |
| Characterization of the Siderophore of Francisella tularensis and Role of fslA in Siderophore Production JT Sullivan, EF Jeffery, JD Shannon, G Ramakrishnan Journal of bacteriology 188 (11), 3785-3795, 2006 | 120 | 2006 |
| The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation KE Zulauf, JT Sullivan, M Braunstein PLoS pathogens 14 (4), e1007011, 2018 | 105 | 2018 |
| Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis IC Allen, E McElvania-TeKippe, JE Wilson, JD Lich, JC Arthur, JT Sullivan, ... PloS one 8 (4), e60842, 2013 | 71 | 2013 |
| Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles DF Tucker, JT Sullivan, KA Mattia, CR Fisher, T Barnes, MN Mabila, R Wilf, ... Proceedings of the National Academy of Sciences 115 (22), E4990-E4999, 2018 | 55 | 2018 |
| Genome-Wide Identification of Mycobacterium tuberculosis Exported Proteins with Roles in Intracellular Growth JR McCann, JA McDonough, JT Sullivan, ME Feltcher, M Braunstein Journal of bacteriology 193 (4), 854-861, 2011 | 44 | 2011 |
| An orphaned Mce‐associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters EF Perkowski, BK Miller, JR McCann, JT Sullivan, S Malik, IC Allen, ... Molecular microbiology 100 (1), 90-107, 2016 | 40 | 2016 |
| High-throughput protein engineering improves the antigenicity and stability of soluble HIV-1 envelope glycoprotein SOSIP trimers JT Sullivan, C Sulli, A Nilo, A Yasmeen, G Ozorowski, RW Sanders, ... Journal of virology 91 (22), 10.1128/jvi. 00862-17, 2017 | 24 | 2017 |
| Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage J Gerhart, J Bowers, L Gugerty, C Gerhart, M Martin, F Abdalla, ... PLoS One 15 (7), e0234792, 2020 | 9 | 2020 |
| Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth VU Chukwuma, N Kose, DN Sather, G Sapparapu, R Falk, H King, ... PLoS One 13 (12), e0209437, 2018 | 8 | 2018 |
| Monoclonal antibody 2C6 targets a cross-clade conformational epitope in gp41 with highly active antibody-dependent cell cytotoxicity H Sojar, S Baron, JT Sullivan, M Garrett, MM van Haaren, J Hoffman, ... Journal of Virology 93 (17), 10.1128/jvi. 00772-19, 2019 | 6 | 2019 |
| IFT&E Industry Report Wind Turbine-Radar Interference Test Summary. B Karlson, BP LeBlanc, DG Minster, M Estill, BE Miller, F Busse, C Keck, ... Sandia National Lab.(SNL-NM), Albuquerque, NM (United States), 2014 | 2 | 2014 |
| Discovery of a novel claudin 6 (CLDN6) specific monoclonal antibody LJ Stafford, B Screnci, C Sulli, E Rosenberg, N Molino, D Tucker, ... Cancer Research 78 (13_Supplement), 5759-5759, 2018 | 1 | 2018 |
| Preclinical safety assessment for specificity of biotherapeutics using the membrane proteome array KS Raghavan, JT Sullivan, C Navia, RH Fong, BJ Doranz Cancer Research 84 (6_Supplement), 5798-5798, 2024 | | 2024 |
| Identifying new cellular adjuvants for cancer vaccines and immunotherapies J Rucker, N Nwogu, NM Molino, A Snyder, JT Sullivan, BJ Doranz Cancer Research 84 (6_Supplement), 6743-6743, 2024 | | 2024 |
| Preclinical Safety Assessment for Specificity of Biotherapeutics Using the Membrane Proteome Array D Norden, R Fong, J Sullivan, C Navia, R Wilf, B Doranz INTERNATIONAL JOURNAL OF TOXICOLOGY 43 (1), 104-105, 2024 | | 2024 |
| Developing an FDA-Qualified Drug Development Tool, the Membrane Proteome Array, for Specificity Testing of Antibodies and CAR-T Cell Therapies M Phelan, DM Norden, JT Sullivan, T Marano, C Navia, RH Fong, A Singh, ... INTERNATIONAL JOURNAL OF TOXICOLOGY 43 (1), 87-88, 2024 | | 2024 |
| De-risk Antibody-Based Therapies by Identifying Off-target Reactivity DM Norden, RH Fong, JT Sullivan, DB Harmon, MA Phelan, T Marano, ... INTERNATIONAL JOURNAL OF TOXICOLOGY 42 (1), 91-91, 2023 | | 2023 |
Irving AllenVirginia Tech, Virginia Maryland College of Veterinary Medicine, Department of Biomedical SciencesVerified email at vt.edu
